389 related articles for article (PubMed ID: 8195049)
1. New metabolites, tetrahydrofuran lignans, produced by Streptomyces sp. IT-44.
Chiung YM; Hayashi H; Matsumoto H; Otani T; Yoshida K; Huang MY; Chen RX; Liu JR; Nakayama M
J Antibiot (Tokyo); 1994 Apr; 47(4):487-91. PubMed ID: 8195049
[No Abstract] [Full Text] [Related]
2. Chrolactomycin, a novel antitumor antibiotic produced by Streptomyces sp.
Nakai R; Kakita S; Asai A; Chiba S; Akinaga S; Mizukami T; Yamashita Y
J Antibiot (Tokyo); 2001 Oct; 54(10):836-9. PubMed ID: 11776440
[No Abstract] [Full Text] [Related]
3. Aranciamycin anhydride, a new anthracycline-type antibiotic isolated from Streptomyces sp. Tü 6384(*).
Nachtigall J; Schulz D; Beil W; Süssmuth RD; Fiedler HP
J Antibiot (Tokyo); 2010 Jul; 63(7):397-9. PubMed ID: 20551987
[No Abstract] [Full Text] [Related]
4. Vicenistatin, a novel 20-membered macrocyclic lactam antitumor antibiotic.
Shindo K; Kamishohara M; Odagawa A; Matsuoka M; Kawai H
J Antibiot (Tokyo); 1993 Jul; 46(7):1076-81. PubMed ID: 8360102
[TBL] [Abstract][Full Text] [Related]
5. Directed biosynthesis of 5"-fluoropactamycin in Streptomyces pactum.
Adams ES; Rinehart KL
J Antibiot (Tokyo); 1994 Dec; 47(12):1456-65. PubMed ID: 7844040
[TBL] [Abstract][Full Text] [Related]
6. A new macrolide antibiotic with antitumor activity produced by Streptomyces sp. CS, a commensal microbe of Maytenus hookeri.
Lu C; Shen Y
J Antibiot (Tokyo); 2003 Apr; 56(4):415-8. PubMed ID: 12817815
[No Abstract] [Full Text] [Related]
7. HS071, a new furan-type cytotoxic metabolite from Streptomyces sp. HS-HY-071.
Wang J; Zhang H; Yang X; Zhou Y; Wang H; Bai H
J Antibiot (Tokyo); 2008 Oct; 61(10):623-6. PubMed ID: 19168976
[TBL] [Abstract][Full Text] [Related]
8. C-1027 enediyne chromophore: presence of another active form and its chemical structure.
Otani T; Yoshida K; Sasaki T; Minami Y
J Antibiot (Tokyo); 1999 Apr; 52(4):415-21. PubMed ID: 10395278
[No Abstract] [Full Text] [Related]
9. Ripromycin and other polycyclic macrolactams from Streptomyces sp. Tü 6239: taxonomy, fermentation, isolation and biological properties.
Bertasso M; Holzenkämpfer M; Zeeck A; Stackebrandt E; Beil W; Fiedler HP
J Antibiot (Tokyo); 2003 Apr; 56(4):364-71. PubMed ID: 12817810
[TBL] [Abstract][Full Text] [Related]
10. Diperamycin, a new antimicrobial antibiotic produced by Streptomyces griseoaurantiacus MK393-AF2. I. Taxonomy, fermentation, isolation, physico-chemical properties and biological activities.
Matsumoto N; Momose I; Umekita M; Kinoshita N; Chino M; Iinuma H; Sawa T; Hamada M; Takeuchi T
J Antibiot (Tokyo); 1998 Dec; 51(12):1087-92. PubMed ID: 10048567
[TBL] [Abstract][Full Text] [Related]
11. Lactonamycin, a new antimicrobial antibiotic produced by Streptomyces rishiriensis MJ773-88K4. I. Taxonomy, fermentation, isolation, physico-chemical properties and biological activities.
Matsumoto N; Tsuchida T; Maruyama M; Kinoshita N; Homma Y; Iinuma H; Sawa T; Hamada M; Takeuchi T; Heida N; Yoshioka T
J Antibiot (Tokyo); 1999 Mar; 52(3):269-75. PubMed ID: 10348042
[TBL] [Abstract][Full Text] [Related]
12. A new antibiotic, 13-hydroxyglucopiericidin A. Isolation, structure elucidation and biological characteristics.
Mori H; Funayama S; Sudo Y; Komiyama K; Omura S
J Antibiot (Tokyo); 1990 Oct; 43(10):1329-31. PubMed ID: 2258331
[No Abstract] [Full Text] [Related]
13. RK-397, a new oxo pentaene antibiotic.
Kobinata K; Koshino H; Kudo T; Isono K; Osada H
J Antibiot (Tokyo); 1993 Oct; 46(10):1616-8. PubMed ID: 8244892
[No Abstract] [Full Text] [Related]
14. Elaiomycins K and L, new azoxy antibiotics from Streptomyces sp. Tü 6399*.
Manderscheid N; Helaly SE; Kulik A; Wiese J; Imhoff JF; Fiedler HP; Süssmuth RD
J Antibiot (Tokyo); 2013 Feb; 66(2):85-8. PubMed ID: 23149516
[TBL] [Abstract][Full Text] [Related]
15. TMC-1 A, B, C and D, new antibiotics of the manumycin group produced by Streptomyces sp. Taxonomy, production, isolation, physico-chemical properties, structure elucidation and biological properties.
Kohno J; Nishio M; Kawano K; Nakanishi N; Suzuki S; Uchida T; Komatsubara S
J Antibiot (Tokyo); 1996 Dec; 49(12):1212-20. PubMed ID: 9031666
[TBL] [Abstract][Full Text] [Related]
16. Two new lankacidin-related metabolites from Streptomyces sp. HS-NF-1178.
Lu C; Li JM; Qi H; Zhang H; Zhang J; Xiang WS; Wang JD; Wang XJ
J Antibiot (Tokyo); 2018 Mar; 71(3):397-401. PubMed ID: 29348529
[TBL] [Abstract][Full Text] [Related]
17. Anthracycline metabolites from Streptomyces violaceus A262. II. New anthracycline epelmycins produced by a blocked mutant strain SU2-730.
Johdo O; Watanabe Y; Ishikura T; Yoshimoto A; Naganawa H; Sawa T; Takeuchi T
J Antibiot (Tokyo); 1991 Oct; 44(10):1121-9. PubMed ID: 1955395
[TBL] [Abstract][Full Text] [Related]
18. NK154183A and B, antitumor substances produced by Streptomyces sp.
Tsuchiya K; Kimura C; Nishikawa K; Harada T; Nishikiori T; Tatsuta K
J Antibiot (Tokyo); 1996 Dec; 49(12):1281-3. PubMed ID: 9031676
[No Abstract] [Full Text] [Related]
19. 10'-Desmethoxystreptonigrin, a novel analog of streptonigrin.
Liu WC; Barbacid M; Bulgar M; Clark JM; Crosswell AR; Dean L; Doyle TW; Fernandes PB; Huang S; Manne V
J Antibiot (Tokyo); 1992 Apr; 45(4):454-7. PubMed ID: 1592677
[TBL] [Abstract][Full Text] [Related]
20. Secondary metabolites by chemical screening, 15. Structure and absolute configuration of naphthomevalin, a new dihydro-naphthoquinone antibiotic from Streptomyces sp.
Henkel T; Zeeck A
J Antibiot (Tokyo); 1991 Jun; 44(6):665-9. PubMed ID: 1906453
[No Abstract] [Full Text] [Related]
[Next] [New Search]
